Site icon

9/2022・Trifork upgrades outlook for 2022 financial results

Trifork Holding AG (“Trifork”) upgrades outlook for the 2022 financial results from what was previously communicated on 16 March 2022 in connection with the announcement of Trifork’s 2021 financial results:

  • Revenue target for the financial year 2022 is increased to EURm 180-185 from EURm 175-180.
  • Trifork Segment adjusted EBITDA target (excluding Trifork Labs and special items) for the financial year 2022 is increased to EURm 30.5-33.0 from EURm 29.5-32.0.
  • Trifork Group EBIT target for the financial year 2022 is increased to EURm 16.5-19.0 from EURm 15.5-18.0.

General development
The upgraded outlook for 2022 is based on an increased operational performance and organic growth in our Digital Health Business Area and a strong inflow of new or renewed framework agreements with existing customers.

Contract signed
As announced in Company announcement no. 5 / 2022 on March 28, Trifork won a strategic tender based on a joint SAP-Trifork cooperation and signed a letter of intent with a Swiss healthcare customer in March. Today, a final agreement has been signed between Swiss-based Bluespace Ventures AG and Trifork, thus making Trifork the Lead Technology Partner to provide advanced healthcare technology.

This is a milestone in Trifork’s effort to bring Digital Health products and services to more markets and also has a positive impact on our financial outlook.

Mid-term targets
Mid-term targets are maintained. Over a three-year period, Trifork Group targets annual average revenue growth of 15-25% with organic revenue growth of 10-15% on average per year over the same period.

Exit mobile version